Brief: Catalyst Biosciences Reports Q2 2022 Results
15/08/2022 22:27
Aug 15 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* CATALYST BIOSCIENCES REPORTS SECOND QUARTER 2022 OPERATING
&
FINANCIAL RESULTS
* CATALYST BIOSCIENCES INC - QTRLY EARNINGS PER SHARE $1.64
Source text for Eikon: ID:nGNX2w3lqq
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes